This medication is an antiprotozoal and antimalarial, prescribed for prevention of malaria, treatment of malaria. It prevents the development of malaria parasites.
Contraindicated in patients with hypersensitivity, severe kidney failure.
Adult: PO- Malaria prophylaxis- 200 mg/day with chloroquine or 100 mg/day with atovaquone. Start 1 week before exposure to malaria or 1-2 days prior to travel. Continue throughout exposure and for at least 4 week (or 1 week if given with atovaquone) after leaving a malaria-infested area.
It comes as a tablet to take by mouth (orally), with food.
• It may not work as well if you have severe or persistent vomiting or diarrhea.
• It may make you drowsy. Do not drive a car or operate machinery while taking this medication.
• Caution needed for patients with history of kidney disease, pregnancy, breast feeding, elderly, and children.
• If you experience with vomiting within one hour after taking this medication, take another dose.
• Most Common in adult:
Abdominal pain, nausea, vomiting, headache, diarrhea, weakness, loss of appetite, and dizziness.
• Children: Vomiting, and itching.
• Kidney: Blood in urine.
• Blood : Abnormally decrease in white blood cells, and rarely anemia. Decrease in all types of blood cells.
• Allergic reactions: Allergic reactions including rapid swelling, hives, rare cases of life-threatening allergies, and inflammation of blood vessels.
• Central Nervous System : Rarely seizures and hallucinations.
• Gastrointestinal : Mouth ulcer.
• Liver: Elevated liver function tests and rare cases of liver inflammation.
• Skin : Photosensitivity, rash, and rare cases of erythema multiforme and Stevens-Johnson syndrome.
Avoid abrupt withdrawal.
Store it in an airtight container; keep away from children and pets.
Subscribe to our Free Newsletters!